肝细胞癌患者的直接抗病毒治疗：治疗时机至关重要。 - Suppr

Direct-acting antiviral therapy in patients with hepatocellular cancer: The timing of treatment is everything.

作者信息

Mazzarelli Chiara, Cannon Mary D, Belli Luca S, Agarwal Kosh

机构信息

Institute of Liver Studies, King's College Hospital, London SE5 9RS, United Kingdom; Hepatology Unit and Gastroenterology, ASST Ospedale Metropolitano Niguarda, P.za dell'ospedale Maggiore 3, 20100 Milan, Italy.

Institute of Liver Studies, King's College Hospital, London SE5 9RS, United Kingdom.

出版信息

J Hepatol. 2017 Sep 21. doi: 10.1016/j.jhep.2017.08.025.

DOI:10.1016/j.jhep.2017.08.025

PMID:28870675

Abstract

摘要

相似文献

Direct-acting antiviral therapy in patients with hepatocellular cancer: The timing of treatment is everything.肝细胞癌患者的直接抗病毒治疗：治疗时机至关重要。

J Hepatol. 2017 Sep 21. doi: 10.1016/j.jhep.2017.08.025.

Reply to: "Direct-acting antiviral therapy in patients with hepatocellular cancer: The timing of treatment is everything" and "More extended indication of DAA therapy in patients with HCC, affordability, and further statistical considerations".回复：“肝细胞癌患者的直接抗病毒治疗：治疗时机至关重要”以及“DAA 疗法在 HCC 患者中的更广泛适应症、可负担性及进一步的统计学考量”

J Hepatol. 2017 Sep 20. doi: 10.1016/j.jhep.2017.09.011.

Inflammatory patterns in plasma associate with hepatocellular carcinoma development in cured hepatitis C cirrhotic patients.血浆中的炎症模式与已治愈的丙型肝炎肝硬化患者肝癌的发展相关。

United European Gastroenterol J. 2021 May;9(4):486-496. doi: 10.1177/2050640620976991. Epub 2021 Feb 18.

Direct-acting antiviral therapy decreases hepatocellular carcinoma recurrence rate in cirrhotic patients with chronic hepatitis C.直接作用抗病毒疗法可降低丙型肝炎肝硬化患者肝癌复发率。

Liver Int. 2017 Aug;37(8):1122-1127. doi: 10.1111/liv.13456. Epub 2017 May 25.

Early development of de novo hepatocellular carcinoma after direct-acting agent therapy: Comparison with pegylated interferon-based therapy in chronic hepatitis C patients.直接作用抗病毒药物治疗后新发肝细胞癌的早期发生：与慢性丙型肝炎患者聚乙二醇干扰素治疗的比较

J Viral Hepat. 2018 Oct;25(10):1189-1196. doi: 10.1111/jvh.12918. Epub 2018 May 17.

Risk of Hepatocellular Cancer Recurrence in Hepatitis C Virus+ Patients Treated with Direct-Acting Antiviral Agents.直接作用抗病毒药物治疗的丙型肝炎病毒感染者肝细胞癌复发风险。

Dig Dis Sci. 2019 Nov;64(11):3328-3336. doi: 10.1007/s10620-019-05641-3. Epub 2019 Apr 30.

[Research progress of direct-acting antiviral drugs in the treatment of chronic hepatitis C-related cirrhosis].直接作用抗病毒药物治疗慢性丙型肝炎相关肝硬化的研究进展

Zhonghua Gan Zang Bing Za Zhi. 2024 Jan 20;32(1):87-90. doi: 10.3760/cma.j.cn501113-20231126-00237.

Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study.直接作用抗病毒治疗后慢性丙型肝炎患者的临床结局：一项前瞻性队列研究。

Lancet. 2019 Apr 6;393(10179):1453-1464. doi: 10.1016/S0140-6736(18)32111-1. Epub 2019 Feb 11.

Hepatitis C virus relapse after successful treatment with direct-acting antivirals, followed by sarcomatous changes in hepatocellular carcinoma: a case report.直接作用抗病毒药物治疗后成功的丙型肝炎病毒复发，随后发生肝细胞癌肉瘤样改变：一例报告。

J Med Case Rep. 2020 May 27;14(1):62. doi: 10.1186/s13256-020-02392-y.

Serum GP88 as a predictive biomarker for hepatocellular carcinoma in patients with viral hepatitis C after direct-acting antiviral agents.血清GP88作为丙型病毒性肝炎患者接受直接抗病毒药物治疗后肝细胞癌的预测生物标志物。

Ann Clin Biochem. 2021 Nov;58(6):605-613. doi: 10.1177/00045632211036723. Epub 2021 Aug 11.

引用本文的文献

Patients Treated for HCV Infection and Listed for Liver Transplantation in a French Multicenter Study: What Happens at Five Years?在法国多中心研究中接受 HCV 感染治疗并被列入肝移植名单的患者：五年后会怎样？

Viruses. 2022 Dec 31;15(1):137. doi: 10.3390/v15010137.

Direct-Acting Antiviral Therapy in Liver Transplant Patients With Hepatocellular Carcinoma and Hepatitis C.肝移植合并肝细胞癌和丙型肝炎患者的直接抗病毒治疗

Transplant Direct. 2020 Dec 8;7(1):e635. doi: 10.1097/TXD.0000000000001049. eCollection 2021 Jan.

Direct-acting antivirals and hepatocellular carcinoma in chronic hepatitis C: A few lights and many shadows.直接作用抗病毒药物与慢性丙型肝炎相关肝细胞癌：喜忧参半。

World J Gastroenterol. 2018 Jun 28;24(24):2582-2595. doi: 10.3748/wjg.v24.i24.2582.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Direct-acting antiviral therapy in patients with hepatocellular cancer: The timing of treatment is everything.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献检索

文件翻译

深度研究

Suppr 超能文献

相似文献

引用本文的文献